Patent: 9,181,337

✉ Email this page to a colleague

Summary for Patent: 9,181,337

Scope and claims summary:

Title:	Modulated lysine variant species compositions and methods for producing and using the same
Abstract:	The instant invention relates to modulated lysine variant species compositions comprising a protein, e.g., an antibody, or antigen-binding portion thereof, and methods, e.g., cell culture and/or protein purification methods, for producing such modulated lysine variant species compositions. Methods for using such compositions to treat a disorder, e.g., a disorder in which TNF.alpha. is detrimental, are also provided.
Inventor(s):	Subramanian; Kartik (Northborough, MA), Perez Thiele; Mayda (Vega Alta, PR), Zeng; Xiaobei (Carolina, PR), Wong; Chee Furng (Singapore, SG), Kaymakcalan; Zehra (Westborough, MA), Jing; Ying (Wellesley, MA), Chumsae; Christopher (North Andover, MA)
Assignee:	AbbVie, Inc. (North Chicago, IL)
Application Number:	14/077,988
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,181,337
Patent Claims:	see list of patent claims

Details for Patent 9,181,337

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Abbvie Inc.	HUMIRA	adalimumab	Injection	125057	December 31, 2002	9,181,337	2033-10-18
Abbvie Inc.	HUMIRA	adalimumab	Injection	125057	February 21, 2008	9,181,337	2033-10-18
Abbvie Inc.	HUMIRA	adalimumab	Injection	125057	April 24, 2013	9,181,337	2033-10-18
Abbvie Inc.	HUMIRA	adalimumab	Injection	125057	September 23, 2014	9,181,337	2033-10-18
Abbvie Inc.	HUMIRA	adalimumab	Injection	125057	November 23, 2015	9,181,337	2033-10-18
Abbvie Inc.	HUMIRA	adalimumab	Injection	125057	March 09, 2016	9,181,337	2033-10-18
Abbvie Inc.	HUMIRA	adalimumab	Injection	125057	October 17, 2016	9,181,337	2033-10-18
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.